We believe in doing well by doing good, combining solid financial returns with societal impact
“Time to understand more to fear less”
We invest in ventures aimed at improving & disrupting healthcare and life sciences through innovation and technology. We look for differentiated approaches, built on solid IP and know-how, by teams that can really drive change.
Enabling technologies in healthcare and life sciences
We focus on solutions that are solving an unmet need in the market. This solution can be hardware, software, services or a combination. We look for innovations that deliver enhanced treatments and care for patients, create actionable insights, or enable efficiency gains throughout the drug development process and during the patient journey.
The transformation that such enabling technologies are inducing in healthcare has the potential to bring substantial value to systems around the world, improving care while also driving down its cost.
Aging global population
Macro-economic trends and demographic shifts are putting healthcare systems under tremendous pressure.
75% of deaths from chronic disease
Cancer, neurodegenerative and cardiovascular diseases contribute to three-quarters of global mortality.
Rising costs
As government budgets cannot keep up, value-based healthcare and real-world evidence are required, putting data centre stage.
Scope and approach
We target companies which can demonstrate feasibility to bring disruptive innovation to market. We engage at seed, Series A and Series B stage, tailoring our investment to achieve the most efficient path to value creation.
To ensure positive impact, we believe it is imperative to be close to our ventures and have frequent interactions. We offer mentorship, hands-on support and operational expertise to the management teams we invest in.
